Glutamine, an abundant amino acid, has many metabolic roles that prote
ct tissue integrity and enhance the immune system. Low plasma and tiss
ue levels of glutamine in the critically-ill suggest that demand may e
xceed endogenous supply and with the profound muscle wasting that occu
rs this supply of gluatmine may become critical to survival. The very
sickest patients who are unable to tolerate enteral feeding are solely
dependent on conventional parenteral nutrition which does not contain
glutamine. This short review, drawing upon a recent double blind rand
omised clinical six month outcome study, provides the rationale to sug
gest that parenteral glutamine supply in these very sick patients may
improve recovery and reduce late mortality.